SCHEMBL16094521

SCHEMBL16094521

O=C(O)c1ccnc(-c2c[nH]c(CCc3ccccc3F)n2)c1

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ KDM5B Q9UGL1 9/20 0.59
▸ KDM5A P29375 8/20 0.59
▸ KDM4C Q9H3R0 11/20 0.55
▸ KDM4A O75164 8/20 0.55
▸ KDM4E B2RXH2 5/20 0.47
▸ KDM5C P41229 5/20 0.47
▸ KDM2A Q9Y2K7 3/20 0.47
▸ KDM3A Q9Y4C1 3/20 0.47
▸ KDM6B O15054 2/20 0.47
▸ AKR1C3 P42330 1/20 0.42
▸ P4HA1 P13674 1/20 0.40
▸ NR3C2 P08235 1/20 0.40
▸ KDM4B O94953 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16095624 0.90 KDM4C (0.56) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16095193 0.87 KDM4C (0.59) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16102028 0.86 KDM4C (0.44) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16094800 0.86 KDM4C (0.61) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16095566 0.84 KDM4C (0.61) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16094928 0.81 KDM5C (0.55) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16095249 0.81 KDM4C (0.57) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16096062 0.79 KDM4C (0.54) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL17604506 0.79 KDM4C (0.54) KDM5BKDM5AKDM4CKDM4AKDM4E
SCHEMBL16095770 0.78 KDM5B (0.45) KDM5BKDM5AKDM4CKDM4AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2969007-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals Inc (US) 2016-01-20 — — EP disclosed
WO-2014151945-A1 HISTONE DEMETHYLASE INHIBITORS Quanticel Pharmaceuticals, Inc. (US) 2014-09-25 — — WO disclosed
Send feedback